List of works - Eike Burandt

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer

scientific article published on 23 September 2019

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

scientific article published on 01 March 2019

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

scientific article published on 13 June 2020

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

scientific article published on 19 November 2019

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

scientific article published on 02 August 2019

Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

scientific article published on 29 November 2019

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

scientific article published on 04 December 2018

Expression of the immune checkpoint receptor TIGIT in seminoma

scientific article published on 31 May 2019

High RSF1 protein expression is an independent prognostic feature in prostate cancer

scientific article published on 05 November 2019

High homogeneity of MMR deficiency in ovarian cancer

scientific article published on 08 January 2020

High homogeneity of mismatch repair deficiency in advanced prostate cancer

scientific article published on 06 December 2019

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

scientific article published on 12 October 2019

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas

scientific article published on 06 March 2020

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

scientific article published on 02 May 2019

Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

scientific article published on 14 November 2018

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

scientific article published on 01 May 2019

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

scientific article published on 01 January 2020

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

scientific article published on 23 February 2010

MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes

scientific article published on 27 February 2020

MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

scientific article published on 14 February 2020

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.

scientific article

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

scientific article published on 10 January 2019

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

scientific article published on 05 March 2020

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

scientific article published on 10 September 2019

Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

scientific article published on 06 July 2020

SNW1 is a prognostic biomarker in prostate cancer